You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV Antibodies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Substance Abuse Among Anti-retroviral Treatment Naive Patients

Completed
  • HIV Infections
  • Substance like alcohol, marijuana, etc.
  • Khagaria, Bihar, India
    ART centre, Sadar Hospital
Mar 16, 2022

Broadly HIV-1 Neutralizing Antibodies in HIV-infected Mbeya,

Active, not recruiting
  • HIV/AIDS
    • Mbeya, Tanzania
      NIMR-Mbeya Medical Research Center (MMRC)
    Aug 5, 2022

    HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

    Not yet recruiting
    • HIV-1-infection
    • VRC07-523LS
    • +7 more
    • Pathum Wan, Bangkok, Thailand
    • +1 more
    Mar 8, 2023

    HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)

    Not yet recruiting
    • HIV Infections
    • VRC01.23LS
    • +2 more
    • Cape Town, Western Cape, South Africa
    • +7 more
    Jul 24, 2023

    Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)

    Not yet recruiting
    • Chronic HIV Infection
    • 426c.Mod.Core-C4b
    • Adjuvant 3M-052-AF+Alum
    • Birmingham, Alabama
    • +6 more
    Aug 17, 2023

    HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

    Suspended
    • HIV Infections
    • Birmingham, Alabama
    • +5 more
    Jan 31, 2023

    HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)

    Completed
    • HIV Antibodies
    • VRC-HIVMAB091-00-AB
    • EDP
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 8, 2022

    HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

    Not yet recruiting
    • HIV Infections
    • Teropavimab
    • +4 more
    • (no location specified)
    Feb 6, 2023

    HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

    Recruiting
    • HIV-1-infection
    • Umlazi, South Africa
      FRESH Clinical Research Site: Females Rising through Education,
    Jan 4, 2023

    HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • +2 more
    • Los Angeles, California
    • +13 more
    Dec 19, 2022

    HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

    Not yet recruiting
    • HIV-1-infection
    • Molepolole, Botswana
    • +8 more
    Sep 8, 2023

    HIV Trial (gp160 MN/LAI-2, Aluminum hydroxide)

    Completed
    • HIV Infections
    • gp160 MN/LAI-2
    • Aluminum hydroxide
    • (no location specified)
    Oct 13, 2021

    HIV/AIDS Trial in Orlando, Boston, Houston (PGT121 + VRC07-523LS, PGT121 + VRC07-523LS + PGDM1400)

    Completed
    • HIV/AIDS
    • PGT121 + VRC07-523LS
    • PGT121 + VRC07-523LS + PGDM1400
    • Orlando, Florida
    • +2 more
    May 6, 2022

    HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

    Recruiting
    • HIV Infection
    • N-803 (IL-15 Superagonist)
    • +2 more
    • Los Angeles, California
    • +11 more
    Sep 22, 2022

    HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

    Recruiting
    • HIV
    • +4 more
    • Ad26.Mos4.HIV
    • +4 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Apr 18, 2022

    Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

    Not yet recruiting
    • Acute HIV Infection
    • VRC07-523LS
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Jan 30, 2023

    COVID-19 Prevalence in HIV-infected Patients

    Active, not recruiting
    • HIV Infections
    • Blood Sample
    • Strasbourg, France
      Hôpitaux Universitaires de Strasbourg
    Aug 2, 2021

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    HIV/AIDS Trial in San Francisco (Combination Intervention)

    Active, not recruiting
    • HIV/AIDS
    • Combination Intervention
    • San Francisco, California
      Zuckerberg San Francisco General Hospital, University of Califor
    Mar 21, 2022

    "Persistence of Neutralizing Antibodies Against Yellow Fever in

    Active, not recruiting
    • HIV Infections
    • Yellow Fever Vaccine
    • Yellow fever neutralizing antibodies measure
    • Antwerp, Belgium
    • +11 more
    Aug 3, 2021

    HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

    Unknown status
    • HIV
    • +2 more
    • Pegylated Interferon alpha 2b (peg-IFN-α2b)
    • 3BNC117 + 10-1074
    • Philadelphia, Pennsylvania
    • +1 more
    Jun 22, 2021

    HIV/AIDS and Infections Trial in London (Investigational Medicinal Product)

    Recruiting
    • HIV/AIDS and Infections
    • Investigational Medicinal Product
    • London, United Kingdom
      Imperial College NHS Healthcare Trust
    Jul 5, 2021

    Pneumococcal Infections, HIV Trial (PPV-23 Vaccine, PCV-13 Vaccine, Placebo Vaccine)

    Withdrawn
    • Pneumococcal Infections
    • HIV Infections
    • PPV-23 Vaccine
    • +2 more
    • (no location specified)
    Oct 28, 2021

    Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

    Not yet recruiting
    • Human Immunodeficiency Virus
    • New York, New York
    • +2 more
    Jul 12, 2022

    HIV/AIDS and Infections Trial in France (Recombinant human mAb (bNAbs), Placebo)

    Not yet recruiting
    • HIV/AIDS and Infections
    • Recombinant human monoclonal antibody (bNAbs)
    • Placebo
    • Bobigny, France
    • +16 more
    Mar 18, 2022